Learning Objectives:
1. Describe the prevalence of neurocognitive impairment in patients with rheumatoid arthritis.
2. Understand the factors that moderate the prevalence of neurocognitive impairment in patients with rheumatoid arthritis.
Pankowski, D., Wytrychiewicz-Pankowska, K., Pisula, E., & Fal, A. M. (2024). Prevalence of neurocognitive impairment in patients with rheumatoid arthritis – a systematic review and meta-analysis. The Clinical Neuropsychologist, 1–21. https://doi.org/10.1080/13854046.2024.2378521
has been added to your cart!
have been added to your cart!